Cancer vaccine prevents deadly melanoma from returning or spreading in landmark trial

Source: Fox News· August 20, 2026
Cancer vaccine prevents deadly melanoma from returning or spreading in landmark trial

Merck and Moderna's mRNA cancer vaccine hit its Phase 3 trial endpoint, showing improved recurrence-free survival in melanoma patients after surgery.

This story was reported by Fox News. Read the full original article:
Read on Fox News

More in Products & Launches

View all